Success Story of Pakshagata
Journal name: Ayushdhara
Original article title: Success Story of Pakshagata
AYUSHDHARA is an international peer-reviewed journal. It focuses on research in Ayurveda, Yoga, Unani, Siddha, Homeopathy, Allopathy, and Pharmaceutical Sciences.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Bhagyashree K
PG Scholar, Dept. of Panchakarma, Government Ayurvedic Medical College, Bengaluru, Karnataka, India.
Megha B
PG Scholar, Dept. of Panchakarma, Government Ayurvedic Medical College, Bengaluru, Karnataka, India.
Ananta S Desai
Head of the Department, Dept. of Panchakarma, Government Ayurvedic Medical College, Bengaluru, Karnataka, India.
Download the PDF file of the original publication
Ayushdhara:
(A peer-reviewed, bi-monthly open-access journal)
Full text available for: Success Story of Pakshagata
Year: 2023 | Doi: 10.47070/ayushdhara.v10i6.1453
Copyright (license): CC BY-NC-SA 4.0
Summary of article contents:
Introduction
Pakshaghata, a significant condition related to the aggravation of Vatadosha, is comparable to hemiplegia and is classified as one of the 80 Vatajananatmajavyadhi. The pathology of Pakshaghata can result from two main mechanisms: Dhatukshaya (tissue depletion) and Margaavarana (obstruction of channels). Globally, cerebrovascular accidents (strokes) affect millions, with a substantial incidence observed in developing countries. In India, the prevalence of hemiplegia hovers around 200 cases per 1,00,000 individuals. This case study discusses a successful treatment approach for a 52-year-old male patient presenting with acute weakness in the left half of his body, diagnosed as Kaphavaranajanya Pakshaghata.
Importance of Kaphavarana
The treatment protocol utilized for the patient specifically addressed Kaphavarana, which was believed to be a contributing factor to his condition. The therapeutic regimen included Agnilepa, a topical application involving various herbs known for their Vatakaphahara (removing Vata and Kapha) properties. Acharya Charaka's guidelines emphasize the importance of Deepana and Pachana therapies for physically weak patients, leading to the initial use of Agnilepa over a week. This intervention aimed to provide nourishment and promote healing through the absorption of therapeutic agents via skin openings.
Role of Nasya in Treatment
Nasya, or nasal administration of herbal preparations, was employed as part of the multifaceted treatment plan. This technique allows drugs to access the head regions through the nasal passage, potentially enhancing cerebral circulation. In this case, a combination of Vacha and Shuntichoorna was used, which, due to their Ushna (hot) and Vatakaphahara properties, aimed to clear obstructions and improve blood flow in ischemic areas. The application of Nasya can help preserve the penumbral region surrounding the infarcted tissue, facilitating better recovery prospects for the patient.
Conclusion
Successful management of Pakshaghata, stemming from either Margaavarana or Dhatukshaya, can significantly enhance patient outcomes when tailored to the specific Dosha and Vyadhiavastha. The case discussed illustrates that a focused approach on addressing Kaphavaranajanya symptoms, using therapies like Agnilepa, Nasya, and Basti, can yield remarkable recovery results. With appropriate and timely intervention, patients can experience substantial symptomatic relief and improvements in their quality of life, highlighting the efficacy of Ayurvedic treatments for complex conditions like Pakshaghata.
FAQ section (important questions/answers):
What is Pakshaghata and how is it related to hemiplegia?
Pakshaghata is an Ayurvedic condition closely resembling hemiplegia, characterized by loss of strength on one side of the body. It occurs mainly due to factors like Dhatukshaya and Margaavarana, manifesting as pronounced motor weakness.
What treatment approach was taken in this case study?
The patient received treatment including Agnilepa, Vachashunti Avapeedaka Nasya, and Dashamulaniruhabasti over a period of 17 days, focusing on alleviating symptoms caused by Kaphavaranajanya Pakshaghata and promoting recovery.
What were the results after the treatment for Pakshaghata?
The treatment led to significant improvement in the patient's Barthel index score, escalating from 30 to 95, indicating enhanced mobility and daily living activities following the Ayurvedic interventions.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Success Story of Pakshagata”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Basti:
In Ayurvedic treatment, Basti refers to an enema therapy that introduces medicated substances into the colon. It is a key procedure in Panchakarma, mainly used for balancing Vata dosha and is often indicated in the management of Vatavyadhi, including neurological conditions like Pakshaghata.
2) Nasya (Nashya):
Nasya is an Ayurvedic treatment involving instillation of medicinal drops into the nostrils. The therapy is particularly effective for ailments affecting the head and neck, such as migraines and sinus problems. In the case study, it was employed to treat Pakshaghata by delivering therapeutic agents directly to the Shiras.
3) Pakshaghata (Paksaghata, Paksha-ghata, Paksha-aghata):
Pakshaghata is an Ayurvedic term for hemiplegia, which is characterized by paralysis affecting one side of the body. It is a type of Vatavyadhi that can result from either Margaavarana or Dhatukshaya. The case study outlines a treatment involving Agnilepa, Nasya, and Basti.
4) Vatavyadhi (Vata-vyadhi):
Vatavyadhi refers to a group of diseases predominantly caused by the aggravation of Vata dosha. These conditions often involve neurological and musculoskeletal issues and are classified as either Kruchrasadhya or Asadhya. Pakshaghata is a specific type of Vatavyadhi diagnosed in the case study.
5) Madhyama:
[see source text or glossary: Madhyama]
6) Dhatukshaya (Dhatuksaya, Dhatu-kshaya):
Dhatukshaya refers to the depletion of bodily tissues or dhatus in Ayurveda. This condition is one of the two primary Samprapti paths for diseases like Pakshaghata, the other being Margaavarana. Treatment focuses on nourishing and restoring balance to the affected dhatus.
7) Samprapti:
Samprapti is the Ayurvedic term for the pathogenesis or progression of a disease. It explains the etiological factors, doshic disturbances, and the affected tissues. In the case study, Pakshaghata's Samprapti involves either Dhatukshaya or Margaavarana, leading to symptoms addressed by Agnilepa, Nasya, and Basti.
8) Vata:
Vata is one of the three primary doshas in Ayurveda, associated with air and space. It governs bodily functions related to movement and coordination. An imbalance in Vata can lead to diseases like Vatavyadhi, including Pakshaghata, characterized by paralysis and neurological deficits.
9) Drug:
[see source text or glossary: Drug]
10) Nature:
[see source text or glossary: Nature]
11) India:
India is the country where the reported case study was conducted. Ayurveda, the traditional system of medicine used in this treatment, has its roots in India. The patient was treated at the Government Ayurveda Medical College in Bengaluru, Karnataka, India.
12) Vatadosha (Vatadosa, Vata-dosha):
Vatadosha is the Ayurvedic term for the biological energy of Vata. Imbalances in this dosha lead to various health conditions, predominantly affecting the nervous and musculoskeletal systems. In the case study, the treatment aimed to pacify aggravated Vata, thereby alleviating Pakshaghata symptoms.
13) Shiras (Siras, Siro, Shirash):
Shiras is the Ayurvedic term for the head. In the context of the case study, the aggravated Vatadosha lodges in the Shiras causing symptoms of Pakshaghata. Treatments like Nasya aim to deliver therapeutic agents directly to the Shiras for effective management.
14) Dosha (Dosa):
Dosha refers to the fundamental bio-energetic forces in Ayurveda, namely Vata, Pitta, and Kapha. An imbalance in any dosha leads to disease. In the case study, addressing the Vatakaphaja symptoms was crucial for treating Pakshaghata.
15) Kapha:
Kapha is one of the three doshas in Ayurveda, associated with water and earth. It governs stability, structure, and fluid balance in the body. In the case study, Kapha's imbalance, identified as Kaphavarana, was treated using Agnilepa and other Panchakarma therapies to manage Pakshaghata.
16) Sira (Shira):
[see source text or glossary: Sira]
17) Agni:
Agni in Ayurveda refers to the digestive fire. Mandaagni, or low digestive fire, can contribute to the pathogenesis of diseases. Treatments often focus on rekindling Agni to promote metabolic balance. This was part of the therapeutic approach in managing Pakshaghata in the case study.
18) Lepa:
Lepa refers to a paste form of medication applied externally in Ayurveda. Agnilepa, a specific type of Lepa used in the case study, consists of herbs with Vatakaphahara, Deepana, and Pachana properties. It was employed to treat Pakshaghata by removing Kaphavarana and pacifying Vata.
19) Margavarodha (Marga-avarodha):
Margavarodha refers to the obstruction of bodily channels or pathways. In Ayurveda, it can be caused by various factors leading to disease. In Pakshaghata, Kaphavarana creates such obstruction, necessitating treatments like Agnilepa, Nasya, and Basti for therapeutic relief.
20) Kaphavata (Kapha-vata):
[see source text or glossary: Kapha-vata]
21) Karnataka:
Karnataka is the Indian state where the Government Ayurveda Medical College in Bengaluru is located. The case study on the successful treatment of Pakshaghata took place in this institution, highlighting the region's contributions to Ayurvedic research and practice.
22) Dashamula (Dasha-mula, Dasamula, Dashan-mula):
Dashamula refers to a traditional Ayurvedic formulation comprising ten roots. It is used for its anti-inflammatory and Vatakaphahara properties. In the case study, Dashamula was used in Kashaya Basti to treat Pakshaghata, promoting the recovery of neurological functions.
23) Ayurveda (Ayus-veda):
Ayurveda is a traditional system of medicine in India, focusing on balance among the body's doshas—Vata, Pitta, and Kapha. The case study employs Ayurvedic principles, including treatments like Agnilepa, Nasya, and Basti, to address Pakshaghata, showcasing Ayurveda's holistic approach to healthcare.
24) Lashuna (Lasuna):
Lashuna, or garlic, is a herb used in Ayurveda for its Vatakaphahara properties. It is a major ingredient in Agnilepa, which was used in the case study to treat Pakshaghata. Garlic also possesses significant thrombolytic activity, aiding in the management of stroke-induced hemiplegia.
25) Asadhya:
Asadhya refers to diseases that are difficult or incurable according to Ayurveda. Vatavyadhi, including Pakshaghata, are often classified as such. The case study demonstrates significant improvement through Ayurvedic treatments, highlighting the potential for managing even Asadhya conditions.
26) Disease:
[see source text or glossary: Disease]
27) Shakti (Sakti):
[see source text or glossary: Shakti]
28) Ananta (Anamta):
Ananta S Desai is one of the authors of the case study and the Head of the Department of Panchakarma at the Government Ayurvedic Medical College in Bengaluru, Karnataka, India. His contribution to the study provides expertise in Ayurvedic practices used to treat Pakshaghata.
29) Nidana:
Nidana refers to the causative factors of a disease in Ayurveda. In the case study, the patient had lifestyle-induced Nidanas like Vishamaashana and Vegadharana, contributing to Pakshaghata. Understanding Nidana is crucial for diagnosis and treatment planning in Ayurvedic practice.
30) Niruha:
[see source text or glossary: Niruha]
31) Megha:
Megha B is a co-author of the case study and a PG Scholar in the Department of Panchakarma at the Government Ayurvedic Medical College in Bengaluru, Karnataka, India. Her work contributes to the understanding and application of Ayurvedic treatments for conditions like Pakshaghata.
32) Ushna (Usna):
[see source text or glossary: Ushna]
33) Ahara:
[see source text or glossary: Ahara]
34) Vaca:
Vacha, also known as Acorus calamus or sweet flag, is a herb used in Ayurveda for its Ushna (hot) and Vatakaphahara properties. In the case study, Vacha was used in Avapeedaka Nasya for treating Pakshaghata, helping to clear Kaphavarana and pacify aggravated Vata dosha.
35) Rasa (Rasha):
[see source text or glossary: Rasa]
36) Rupa:
[see source text or glossary: Rupa]
37) Vyayamashakti (Vyayamasakti, Vyayama-shakti):
[see source text or glossary: Vyayama-shakti]
38) Niruhabasti (Niruha-basti):
Niruhabasti is a type of Basti therapy in Ayurveda where a decoction-based enema is administered. In the case study, Dashamula Kashaya Niruhabasti was used to treat Pakshaghata. This therapy helps in balancing Vata dosha, reducing inflammation, and improving neurological functions.
39) Aharashakti (Aharasakti, Ahara-shakti):
[see source text or glossary: Ahara-shakti]
40) Shalaparni (Salaparni):
[see source text or glossary: Shalaparni]
41) Agnimantha (Agni-mantha, Agnimamtha):
[see source text or glossary: Agnimantha]
42) Majjagni (Majja-agni):
[see source text or glossary: Majja-agni]
43) Bastikarman (Bastikarma, Basti-karman, Basti-karma):
[see source text or glossary: Bastikarma]
44) Discussion:
The discussion section of the case study elaborates on the pathogenesis and treatment approach for Pakshaghata. It explains the relevance of Agnilepa, Nasya, and Basti in removing Kaphavarana and pacifying Vata. The section also highlights the patient's significant improvement in symptoms and mobility.
45) Anuvasana:
[see source text or glossary: Anuvasana]
46) Nagavalli (Naga-valli):
[see source text or glossary: Nagavalli]
47) Samhanana:
[see source text or glossary: Samhanana]
48) Adhishthana (Adhisthana):
[see source text or glossary: Adhistana]
49) Shodhana (Sodhana):
[see source text or glossary: Shodhana]
50) Gambhari:
[see source text or glossary: Gambhari]
51) Shyonaka (Syonaka):
[see source text or glossary: Shyonaka]
52) Sarshapa (Sarsapa):
[see source text or glossary: Sarshapa]
53) Pradhana:
[see source text or glossary: Pradhana]
54) Romakupa (Roman-kupa):
[see source text or glossary: Romakupa]
55) Prakriti (Prakrti):
[see source text or glossary: Prakriti]
56) Nirgundi (Nirgumdi):
[see source text or glossary: Nirgundi]
57) Medicine:
[see source text or glossary: Medicine]
58) Vomiting:
[see source text or glossary: Vomiting]
59) Sweating (Sweat):
[see source text or glossary: Sweating]
60) Madhura:
[see source text or glossary: Madhura]
61) Pramana:
[see source text or glossary: Pramana]
62) Vyayama:
[see source text or glossary: Vyayama]
63) Avyakta:
[see source text or glossary: Avyakta]
64) Vikriti (Vikrti):
[see source text or glossary: Vikriti]
65) Ghataka:
[see source text or glossary: Ghataka]
66) Haridra:
[see source text or glossary: Haridra]
67) Kashaya (Kasaya):
[see source text or glossary: Kashaya]
68) Lavanga (Lavamga):
[see source text or glossary: Lavanga]
69) Nostril:
[see source text or glossary: Nostril]
70) Dravya:
[see source text or glossary: Dravya]
71) Vidahi:
[see source text or glossary: Vidahi]
72) Sevana:
[see source text or glossary: Sevana]
73) Tulasi:
[see source text or glossary: Tulasi]
74) Sadhya:
[see source text or glossary: Sadhya]
75) Shigru (Sigru):
[see source text or glossary: Shigru]
[Note: The above list is limited to 75. Total glossary definitions available: 99]
Other Health Sciences Concepts:
Discover the significance of concepts within the article: ‘Success Story of Pakshagata’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:
Nasya, Basti, Vatavyadhi, Dhatukshaya, Ayurvedic Medical College, Panchakarma procedure, Enteric Nervous System, Margaavarana, Gut-brain axis, Barthel index, Radiological Changes, Cerebrovascular Accident CVA, Therapeutic drug.